July 25, 2019
iBio has expanded its CDMO service offerings to include independent sterile liquid cGMP fill-finish services to support the preclinical and clinical trial needs of drug developers. This new service complements iBio’s existing biologics bulk drug ...
Continue ReadingMay 30, 2019
iBio offers development and manufacturing services for biologic drug substances and drug products, built around our proprietary plant-based platform technology. Client support is offered from early development through fill and finish for research-grade, ...
Continue ReadingMay 24, 2019
Mammalian cell culture is widely used for biologic drug substance production, but the high cost and long development times pose challenges to the implementation of this technology in many parts of the world. Traditional protein expression systems are ...
Continue ReadingFebruary 22, 2019
Imagine you work at a virtual biopharma with a highly specialized biopharmaceutical ready for advanced development. You contact the one CDMO that you’ve been told undoubtedly has the most experience in your field.
Continue ReadingFebruary 19, 2019
The current trade conflict between the world's biggest economies — the United States and China — has resulted in both countries imposing billions of dollars’ worth of tariffs on each other’s goods. At the time of writing, U.S. and Chinese officials are ...
Continue Reading